ABSTRACT
This study compared the prognostic value of quantified thoracic artery calcium (TAC) including aortic arch on chest CT and coronary artery calcium (CAC) score on ECG-gated cardiac CT. METHODS: A total of 2412 participants who underwent both chest CT and ECG-gated cardiac CT at the same period were included in the Multi-Ethnic Study of Atherosclerosis Exam 5. All participants were monitored for incident atherosclerotic cardiovascular disease (ASCVD) events. TAC is defined as calcification in the ascending aorta, aortic arch and descending aorta on chest CT. The quantification of TAC was measured using the Agatston method. Time-dependent receiver-operating characteristic (ROC) curves were used to compare the prognostic value of TAC and CAC scores. RESULTS: Participants were 69±9 years of age and 47% were male. The Spearman correlation between TAC and CAC scores was 0.46 (p<0.001). During the median follow-up period of 8.8 years, 234 participants (9.7%) experienced ASCVD events. In multivariable Cox regression analysis, TAC score was independently associated with increased risk of ASCVD events (HR 1.31, 95% CI 1.09 to 1.58) as well as CAC score (HR 1.82, 95% CI 1.53 to 2.17). However, the area under the time-dependent ROC curve for CAC score was greater than that for TAC score in all participants (0.698 and 0.641, p=0.031). This was particularly pronounced in participants with borderline/intermediate and high 10-year ASCVD risk scores. CONCLUSION: Our study demonstrated a significant association between TAC and CAC scores but a superior prognostic value of CAC score for ASCVD events. These findings suggest TAC on chest CT provides supplementary data to estimate ASCVD risk but does not replace CAC on ECG-gated cardiac CT.
Subject(s)
Coronary Artery Disease , Vascular Calcification , Humans , Male , Female , Aged , Vascular Calcification/diagnostic imaging , Vascular Calcification/epidemiology , Coronary Artery Disease/diagnostic imaging , Coronary Artery Disease/epidemiology , Coronary Artery Disease/diagnosis , Prognosis , Middle Aged , Risk Assessment/methods , Computed Tomography Angiography , Predictive Value of Tests , Aorta, Thoracic/diagnostic imaging , Risk Factors , Aortic Diseases/diagnostic imaging , Aortic Diseases/epidemiology , Aortic Diseases/diagnosis , ROC Curve , Coronary Vessels/diagnostic imaging , Cardiac-Gated Imaging Techniques , United States/epidemiology , Electrocardiography , Incidence , Coronary Angiography/methods , Tomography, X-Ray Computed , Atherosclerosis/epidemiology , Atherosclerosis/diagnosisABSTRACT
BACKGROUND AND AIMS: Copper is an essential dietary element with a crucial role in physiological regulation. However, the relationship between dietary copper intake and abdominal aortic calcification (AAC) remains uncertain. METHODS AND RESULTS: This study encompassed a cohort of 2535 adults aged over 40 years, derived from the National Health and Nutrition Examination Survey 2013-2014. Dietary copper intake from both food sources and supplements was assessed through two 24-h dietary recall interviews. AAC was measured by dual-energy X-ray absorptiometry and classified into 3 groups using the Kauppila score system. Multivariable logistic regression models were constructed to evaluate the association between dietary copper intake and AAC. Among the participants, a total of 771 individuals (30.4%) were diagnosed with AAC, of which 239 (9.4%) exhibited severe AAC. Higher dietary copper intake was significantly associated with a lower incidence of severe AAC. Specifically, for each 1 mg/day increase in dietary copper intake, the incidence of severe AAC decreased by 38% (odds ratios [OR] 0.62, 95% confidence intervals [CI] 0.39-0.98) after adjustment for relevant covariates. Moreover, individuals in the third tertile of copper intake had a 37% lower incidence of AAC compared to those in the first tertile [OR 0.63, 95% CI (0.43-0.95)]. However, no significant associations were found between supplemental copper intake or serum copper levels and AAC. CONCLUSIONS: This study demonstrates that lower dietary copper intake, rather than serum copper levels or supplement copper intake, is significantly associated with a higher prevalence of AAC in adults ≥40 years old in the United States.
Subject(s)
Aortic Diseases , Vascular Calcification , Humans , Adult , United States/epidemiology , Middle Aged , Nutrition Surveys , Cross-Sectional Studies , Copper/adverse effects , Vascular Calcification/diagnostic imaging , Vascular Calcification/epidemiology , Nutritional Status , Aorta, Abdominal/diagnostic imaging , Aortic Diseases/diagnostic imaging , Aortic Diseases/epidemiology , Risk FactorsABSTRACT
OBJECTIVE: We sought to detail the process of establishing a surgical aortic telehealth program and report the outcomes of a 5-year experience. METHODS: A telehealth program was established between two regional Veterans Affairs hospitals, one of which was without a comprehensive aortic surgical program, until such a program was established at the referring institution. A retrospective review was performed of all patients who underwent aortic surgery from 2014 to 2019. The operative data, demographics, perioperative complications, and follow-up data were reviewed. RESULTS: From 2014 to 2019, 109 patients underwent aortic surgery for occlusive and aneurysmal disease. Preoperative evaluation and postoperative follow-up were done remotely via telehealth. The median age of the patients was 68 years, 107 were men (98.2%), 28 (25.7%) underwent open aortic repair, and 81 (74.3%) underwent endovascular repair. Of the 109 patients, 101 (92.7%) had a median follow-up of 24.3 months, 5 (4.6%) were lost to follow-up or were noncompliant, 2 (1.8%) were noncompliant with their follow-up imaging studies but responded to telephone interviews, and 1 (0.9%) moved to another state. At the 30-day follow-up, eight patients (7.3%) required readmission. Four complications were managed locally, and four patients (3.6%) required transfer back to the operative hospital for additional care. CONCLUSIONS: Telehealth is a great tool to provide perioperative care and long-term follow-up for patients with aortic pathologies in remote locations. Most postoperative care and complications can be managed remotely, and patient compliance for long-term follow-up is high.
Subject(s)
Aortic Diseases/surgery , Delivery of Health Care, Integrated/organization & administration , Endovascular Procedures , Outcome and Process Assessment, Health Care/organization & administration , Telemedicine/organization & administration , Vascular Surgical Procedures/organization & administration , Videoconferencing/organization & administration , Aged , Aortic Diseases/diagnostic imaging , Endovascular Procedures/adverse effects , Female , Humans , Male , Middle Aged , Patient Compliance , Patient Readmission , Postoperative Complications/etiology , Postoperative Complications/surgery , Program Evaluation , Reoperation , Retrospective Studies , Time Factors , Treatment Outcome , United States , United States Department of Veterans Affairs , Vascular Surgical Procedures/adverse effectsABSTRACT
In clinical practice, clinicians often meet patients suffering from mid-back pain. One of the possible causes of mid-back pain is penetrating atherosclerotic aortic ulcer (PAU), but the diagnosis is often delayed owing to its low incidence. Here, we report a patient with mid-back pain due to a PAU, who was diagnosed after receiving several procedures for reducing musculoskeletal pain. A 65-year-old man visited our pain clinic for mid-back pain [numeric rating scale (NRS): 7] experienced for 2 months. The pain was radiated to the lateral chest area and was aggravated when in the supine and standing positions. Trigger point injection, medial branch block, and pulsed radiofrequency were ineffective. The cardiac evaluation and abdominal computed tomography (CT) results showed no abnormalities. On CT aortography at 3 months after pain onset, intraluminal thrombus, multiple ruptured PAUs, and aneurysmal change of the descending thoracic aorta were found. Accordingly, PAU was diagnosed as the origin of the patient's pain. We administered nicardipine with a rate of 1.15 mcg/kg/min and esmolol with a rate of 100 mcg/kg/min for controlling the systolic blood pressure. In addition, an anticoagulant was administered orally. To alleviate the pain, we further administered intravenous opioid. Approximately 6 h after, the systolic blood pressure decreased to 100-120 mmHg, and the pain rating decreased to NRS 1. Two weeks after the discharge, the patient's pain rating was sustained at NRS 1. Clinicians should be aware of the fact that PAU can be a cause of mid-back or chest pain.
Subject(s)
Aortic Diseases , Atherosclerosis , Aged , Aortic Diseases/diagnostic imaging , Aortography , Back Pain , Humans , Male , UlcerABSTRACT
BACKGROUND: Renal transplant recipients (RTRs) exhibit increased vascular stiffness and calcification; these parameters are associated with increased cardiovascular risk. Activity of endogenous calcification inhibitors such as matrix gla protein (MGP) is dependent on vitamin K. RTRs commonly have subclinical vitamin K deficiency. The Vitamin K in kidney Transplant Organ Recipients: Investigating vEssel Stiffness (ViKTORIES) study assesses whether vitamin K supplementation reduces vascular stiffness and calcification in a diverse population of RTR. METHODS AND ANALYSIS: ViKTORIES (ISRCTN22012044) is a single-centre, phase II, parallel-group, randomised, double-blind, placebo-controlled trial of the effect of vitamin K supplementation in 90 prevalent RTR. Participants are eligible if they have a functioning renal transplant for >1 year. Those on warfarin, with atrial fibrillation, estimated glomerular filtration rate <15 mL/min/1.73 m2 or contraindications to MRI are excluded. Treatment is with vitamin K (menadiol diphosphate) 5 mg three times per week for 1 year or matching placebo. All participants have primary and secondary endpoint measures at 0 and 12 months. The primary endpoint is ascending aortic distensibility on cardiac MR imaging. Secondary endpoints include vascular calcification (coronary artery calcium score by CT), cardiac structure and function on MR, carotid-femoral pulse wave velocity, serum uncarboxylated MGP, transplant function, proteinuria and quality of life. The study is powered to detect 1.0×10-3 mm Hg-1 improvement in ascending aortic distensibility in the vitamin K group relative to placebo at 12 months. Analyses will be conducted as between-group differences at 12 months by intention to treat. DISCUSSION: This trial may identify a novel, inexpensive and low-risk treatment to improve surrogate markers of cardiovascular risk in RTR.
Subject(s)
Aortic Diseases/prevention & control , Coronary Artery Disease/prevention & control , Dietary Supplements , Kidney Transplantation , Vascular Calcification/prevention & control , Vascular Stiffness/drug effects , Vitamin K/analogs & derivatives , Aortic Diseases/diagnostic imaging , Aortic Diseases/etiology , Clinical Trials, Phase II as Topic , Coronary Artery Disease/diagnostic imaging , Coronary Artery Disease/etiology , Dietary Supplements/adverse effects , Double-Blind Method , Humans , Kidney Transplantation/adverse effects , Randomized Controlled Trials as Topic , Scotland , Time Factors , Vascular Calcification/diagnostic imaging , Vascular Calcification/etiology , Vitamin K/administration & dosage , Vitamin K/adverse effectsABSTRACT
Vascular calcification (VC) is a well-known complication in patients with chronic kidney disease (CKD). Keeping in mind, the end goal to assess the genuine effect of mineral bone disease in the pathogenesis of blood vessel calcification during the pre-dialysis course of CKD, we assessed the prevalence and extent of abdominal aortic calcification (AAC) in nondiabetic CKD patients recently starting hemodialysis (HD). Eighty-one patients with end-stage renal disease beginning HD over a one-month period were selected. They underwent a detailed clinical examination and laboratory evaluation, including serum calcium, phosphorus, parathyroid hormone, fibroblast growth factor (FGF-23), and alkaline phosphatase were measured, and spiral computed tomography was performed to evaluate AAC score. AAC was present in 64 patients (79%). There was a significant correlation between the AAC score and age (r = 0.609, P <0.001) and FGF-23 (r = 0.800, P <0.001). This study suggests that the prevalence and extent of AAC are critical in incident HD patients. Serum FGF-23 level is the sole statistically significant correlate of AAC in these patients.
Subject(s)
Aorta, Abdominal , Aortic Diseases/epidemiology , Kidney Failure, Chronic/therapy , Renal Dialysis , Vascular Calcification/epidemiology , Adult , Aged , Aorta, Abdominal/diagnostic imaging , Aortic Diseases/blood , Aortic Diseases/diagnostic imaging , Aortography/methods , Biomarkers/blood , Computed Tomography Angiography , Egypt/epidemiology , Female , Fibroblast Growth Factor-23 , Fibroblast Growth Factors/blood , Humans , Kidney Failure, Chronic/diagnosis , Kidney Failure, Chronic/epidemiology , Male , Middle Aged , Parathyroid Hormone/blood , Phosphorus/blood , Prevalence , Renal Dialysis/adverse effects , Risk Factors , Time Factors , Tomography, Spiral Computed , Treatment Outcome , Vascular Calcification/blood , Vascular Calcification/diagnostic imaging , Young AdultABSTRACT
OBJECTIVE: The objective of this study was to report the methodology and 1-year experience of a regional service model of teleconsultation for planning and treatment of complex thoracoabdominal aortic disease (TAAD). METHODS: Complex TAADs without a feasible conventional surgical repair were prospectively evaluated by vascular surgeons of the same public health service (National Health System) located in a huge area of 22,994 km2 with 3.7 million inhabitants and 11 tertiary hospitals. Surgeons evaluated computed tomography scans and clinical details that were placed on a web platform (Google Drive; Google, Mountain View, Calif) and shared by all surgeons. Patients gave informed consent for the teleconsultation. The surgeon who submits a case discusses in detail his or her case and proposes a possible therapeutic strategy. The other surgeons suggest other solutions and options in terms of grafts, techniques, or access to be used. Computed tomography angiography, angiography, and clinical outcomes of cases are then presented at the following telemeetings, and a final agreement of the operative strategy is evaluated. Teleconsultation is performed using a web conference service (WebConference.com; Avaya Inc, Basking Ridge, NJ) every month. An inter-rater agreement statistic was calculated, and the κ value was interpreted according to Altman's criteria for computed tomography angiography measurements. RESULTS: The rate of participation was constant (mean number of surgeons, 11; range, 9-15). Twenty-four complex TAAD cases were discussed for planning and operation during the study period. The interobserver reliability recorded was moderate (κ = 0.41-0.60) to good (κ = 0.61-0.80) for measurements of proximal and distal sealing and very good (κ = 0.81-1) for detection of any target vessel angulation >60 degrees, significant calcification (circumferential), and thrombus presence (>50%). The concordance for planning and therapeutic strategy among all participants was complete in 16 cases. In one case, the consultation was decisive for creating an innovative therapeutic strategy; in the remaining seven cases, the strategy proposed by the patient's surgeon was changed completely after the discussion. Technical success was the same (100%) if concordance in planning was present initially or not. Overall 6-month mortality was 4%, 0% for those patients with initial concordance in planning vs 12% for those without initial concordance (P = .33). Surgery was always performed in a tertiary hospital by local surgeons, and in two cases (8%) external surgeons joined the local surgical team. CONCLUSIONS: Such a regional service of teleconsultation may be of value in standardizing the treatment and derived costs of complex TAADs in a huge region under the same health provider. The shared decision-making strategy may be of medical-legal value as well.
Subject(s)
Aorta, Abdominal , Aorta, Thoracic , Aortic Diseases , Aortography/methods , Computed Tomography Angiography , Delivery of Health Care, Integrated/organization & administration , Referral and Consultation/organization & administration , Regional Health Planning/organization & administration , Remote Consultation/organization & administration , Teleradiology/organization & administration , Aorta, Abdominal/diagnostic imaging , Aorta, Abdominal/surgery , Aorta, Thoracic/diagnostic imaging , Aorta, Thoracic/surgery , Aortic Diseases/diagnostic imaging , Aortic Diseases/surgery , Clinical Decision-Making , Cooperative Behavior , Feasibility Studies , Humans , Interdisciplinary Communication , Italy , Observer Variation , Predictive Value of Tests , Program Evaluation , Prospective Studies , Reproducibility of Results , Time Factors , Treatment OutcomeABSTRACT
ETHNOPHARMACOLOGICAL RELEVANCE: The Angong Niuhuang Pill (ANP) is a well known Chinese traditional therapeutic for the treatment for diseases affecting the Central Nervous System (CNS). Components of the ANP formulation, including Bovis Calculus Sativus, Pulvis Bubali Comus Concentratus, Moschus, Margarita, Cinnabaris, Realgar, Coptidis Rhizoma, Scutellariae Radix, Gardeniae Fructus, Curcumae Radix, and Bomeolum Syntheticum, have been used for the treatment of stroke, encephalitis and emergency meningitis across Asia, especially in China for hundreds of years. OBJECTIVE: The goal of this study was to investigate the anti-atherosclerosis and cardio-protective effects of ANP administration using a rodent model of atherosclerosis induced by a high fat and vitamin D3. METHODS: Specific Pathogen-Free (SPF) 78 male SD rats were randomly divided into a control group and 5 atherosclerotic model groups. The atherosclerotic groups were divided to receive either Simvastatin (SVTT, 0.005g/kg), Low-dose ANP (0.125g/kg), Medium-dose ANP (0.25g/kg), and High-dose ANP (0.5g/kg). Following adaptive feeding for one week, atherosclerosis was induced and the atherosclerosis model was established. Experimental drugs (either simvastatin or ANP) or normal saline were administered intragastrically once daily for 9 weeks starting from the 8th week. A carotid artery ultrasound was performed at the 17th week to determine whether atherosclerosis had been induced. After the atherosclerosis model was successfully established, platelet aggregation rates, serum biochemical indices, apoptosis-related Bcl-2, Bax proteins levels in the heart were assayed. Pathological and histological analysis was completed using artery tissue from different experimental different groups to assess the effects of ANP. RESULTS: ANP signiï¬cantly decreased aortic membrane thickness, the maximum platelet aggregation rates, and the ratio of low density lipoprotein cholesterol (LDL) to high density lipoprotein cholesterol (HDL). In addition, ANP signiï¬cantly reduced serum contents of total cholesterol, low density lipoprotein, malondialdehyde, troponin I, high-sensitivity C-reactive protein, and lactate dehydrogenase. ANP markedly improved abnormal pathological conditions of the aorta and heart, and helped to prevent myocardial apoptosis. CONCLUSIONS: We have demonstrated that ANP has robust ant-atherosclerosis and cardio-protective effects on a high-fat and vitamin D3 - induced rodent model of atherosclerosis due to its antiplatelet aggregation, lipid regulatory, antioxidant, anti-inflammatory and anti-apoptotic properties.
Subject(s)
Aortic Diseases/prevention & control , Atherosclerosis/prevention & control , Carotid Artery Diseases/prevention & control , Cholecalciferol , Diet, High-Fat , Drugs, Chinese Herbal/pharmacology , Hypolipidemic Agents/pharmacology , Animals , Anti-Inflammatory Agents/pharmacology , Antioxidants/pharmacology , Aorta, Thoracic/drug effects , Aorta, Thoracic/metabolism , Aorta, Thoracic/ultrastructure , Aortic Diseases/blood , Aortic Diseases/chemically induced , Aortic Diseases/diagnostic imaging , Apoptosis/drug effects , Atherosclerosis/blood , Atherosclerosis/chemically induced , Atherosclerosis/diagnostic imaging , Biomarkers/blood , Carotid Artery Diseases/blood , Carotid Artery Diseases/chemically induced , Carotid Artery Diseases/diagnostic imaging , Disease Models, Animal , Enzymes/blood , Hydroxymethylglutaryl-CoA Reductase Inhibitors/pharmacology , Inflammation Mediators/blood , Lipids/blood , Male , Myocardium/pathology , Platelet Aggregation/drug effects , Platelet Aggregation Inhibitors/pharmacology , Rats, Sprague-Dawley , Simvastatin/pharmacology , Tablets , Time FactorsABSTRACT
Purpose To prospectively develop individualized low-volume contrast media (CM) protocols adapted to tube voltage in patients undergoing computed tomographic (CT) angiography of the aorta. Materials and Methods The study was approved by the institutional review board and local ethics committee. All patients provided written informed consent. CT angiography was performed by using automated attenuation-based tube voltage selection (ATVS) (range, 70-150 kVp; 10-kVp increments). Iodine attenuation curves from an ex vivo experiment in a phantom were used to design CM protocols for CT angiography of the thoracoabdominal aorta in 129 consecutive patients (hereafter, cohort A). Further modified CM protocols based on results in cohort A were designed with the aim of homogeneous vascular attenuation of 300-350 HU across tube voltages and were applied to another 61 consecutive patients (cohort B). Three independent blinded radiologists assessed subjective image quality, and one reader determined objective image quality. The Kruskal-Wallis test was performed to test for differences in subjective image quality, and linear regression was performed to test for differences in objective image quality between the automatically selected tube voltages. Results Experiments revealed tube voltage-dependent iodine attenuation curves, which were used to determine the CM protocols in cohort A; these ranged from 68 mL at 110 kVp to 45 mL at 80 kVp. In both cohorts, ATVS selected 80 kVp in 62 patients, 90 kVp in 84, 100 kVp in 33, and 110 kVp in 11. In cohort A, image quality that was satisfactory or better was attained in 126 (98%) of 129 patients who had no significant differences in subjective image quality between tube voltages (P = .106) but who did have significant differences in attenuation and contrast-to-noise ratio (CNR) (P < .001 for both). In cohort B, the further-modified CM protocol (from 33 mL at 80 kVp to 68 mL at 110 kVp) yielded image quality that was satisfactory or better in all 61 (100%) patients, without significant differences in subjective image quality (P = .178), and without significant differences between tube voltage and attenuation (P = .108), noise (P = .250), or CNR (P = .698). Conclusion Individualized low-volume CM protocols based on automatically selected tube voltages are feasible and yield diagnostic image quality for CT angiography of the aorta. (©) RSNA, 2016 Online supplemental material is available for this article.
Subject(s)
Aortic Diseases/diagnostic imaging , Computed Tomography Angiography , Contrast Media/administration & dosage , Aged , Female , Humans , Male , Middle Aged , Phantoms, Imaging , Prospective Studies , Radiographic Image Interpretation, Computer-AssistedABSTRACT
OBJECTIVE: Thoracic aorta calcium (TAC) is measurable on the same computed tomography (CT) scan as coronary artery calcium (CAC) but has still unclear clinical value. We assessed TAC and CAC relations with non-cardiac vascular events history in a cohort of subjects at risk for cardiovascular disease. METHODS: We analyzed retrospectively 1000 consecutive subjects having undergone CAC detection by non-contrast multi-slice CT with measurement field longer than usual in order to measure total TAC including aortic arch calcium. We also determined partial TAC restricted to ascending and descending thoracic aorta sites by removing arch calcium from total TAC. Calcium deposits were measured with a custom made software using Agatston score. RESULTS: Compared with the rest of the cohort, the 30 subjects with non-cardiac vascular event history had higher median values [95% CI] of total TAC (282 [28-1809] vs 39 [0-333], p < 0.01) and partial TAC (4 [0-284] vs 0 [0-5], p < 0.01) but no different value of CAC (73 [0-284] vs 16 [0-148]). Odds ratio [95% CI] of having non-cardiac vascular event per 1-SD increase in log-transformed calcium value was significant for total TAC but not for CAC, if total TAC and CAC were entered separately (1.56 [1.12-2.24], p < 0.01 and 1.13 [0.86-1.50], respectively) or together (1.57 [1.10-2.32], p < 0.01 and 0.98 [0.73-1.32], respectively) in the logistic adjusted model. CONCLUSION: TAC assessment simultaneous with CAC detection provides complementary information on the extra coronary component of cardiovascular risk beyond CAC's coronary risk prediction. Further studies are required to prospectively confirm this result.
Subject(s)
Aorta, Thoracic/diagnostic imaging , Aortic Diseases/diagnostic imaging , Calcinosis/diagnostic imaging , Calcium/metabolism , Coronary Artery Disease/diagnostic imaging , Aorta, Thoracic/metabolism , Aortic Diseases/complications , Aortic Diseases/epidemiology , Argentina/epidemiology , Calcinosis/metabolism , Coronary Angiography , Coronary Artery Disease/epidemiology , Coronary Artery Disease/etiology , Female , Follow-Up Studies , France/epidemiology , Humans , Incidence , Male , Middle Aged , Multidetector Computed Tomography , Retrospective Studies , Risk AssessmentABSTRACT
Chronic disseminated intravascular coagulation is a rare complication of aortic dissection. Surgical correction or low molecular weight heparin is treatment of choice, but for a severe bleeding problem due to excessive fibrinolysis, para-aminomethylbenzoic acid would be a simple and effective therapeutic approach.
Subject(s)
Antifibrinolytic Agents/therapeutic use , Aortic Diseases/complications , Aortic Dissection/complications , Disseminated Intravascular Coagulation/drug therapy , para-Aminobenzoates/therapeutic use , Aortic Dissection/diagnostic imaging , Aortic Diseases/diagnostic imaging , Aortography , Blood Vessel Prosthesis Implantation , Chronic Disease , Disseminated Intravascular Coagulation/etiology , Drugs, Chinese Herbal/therapeutic use , Endovascular Procedures , Fibrin Fibrinogen Degradation Products/analysis , Fibrinogen/analysis , Hematuria/etiology , Humans , Male , Middle Aged , Salvia miltiorrhiza , Stents , Tomography, X-Ray ComputedABSTRACT
PURPOSE: Diagnosis and management of thoracic aorta (TA) disease demand the assessment of accurate quantitative information of the aortic anatomy. We investigated the principal modes of variation in aortic 3-dimensional geometry paying particular attention to the curvilinear portion. MATERIALS AND METHODS: Images were obtained from extended noncontrast multislice computed tomography scans, originally intended for coronary calcium assessment. The ascending, arch, and descending aortas of 500 asymptomatic patients (57 ± 9 y, 81% male) were segmented using a semiautomated algorithm that sequentially inscribed circles inside the vessel cross-section. Axial planes were used for the descending aorta, whereas oblique reconstructions through a toroid path were required for the arch. Vessel centerline coordinates and the corresponding diameter values were obtained. Twelve size and shape geometric parameters were calculated to perform a principal component analysis. RESULTS: Statistics revealed that the geometric variability of the TA was successfully explained using 3 factors that account for â¼80% of total variability. Averaged aortas were reconstructed varying each factor in 5 intervals. Analyzing the parameter loadings for each principal component, the dominant contributors were interpreted as vessel size (46%), arch unfolding (22%), and arch symmetry (12%). Variables such as age, body size, and risk factors did not substantially modify the correlation coefficients, although some particular differences were observed with sex. CONCLUSIONS: We conclude that vessel size, arch unfolding, and symmetry form the basis for characterizing the variability of TA morphology. The numerical data provided in this study as supplementary material can be exploited to accurately reconstruct the curvilinear shape of normal TAs.
Subject(s)
Aorta, Thoracic/pathology , Aortic Diseases/pathology , Adult , Aged , Aged, 80 and over , Algorithms , Aorta, Thoracic/diagnostic imaging , Aortic Diseases/diagnostic imaging , Body Surface Area , Female , Humans , Image Processing, Computer-Assisted , Male , Middle Aged , Multidetector Computed Tomography , Principal Component Analysis , Retrospective StudiesABSTRACT
After cisplatin / 5-fluorouracil chemotherapy for nasopharyngeal carcinoma, an 18-year female patient developed aortobifemoral embolism. Besides chemotherapy, additional risk factors for arterial thromboembolic events were smoking, contraceptive medication and adjuvant antiemetic treatment with dexamethasone. Thrombophilia screening was negative. Thromboembolic complications during or after cisplatin have been reported in a frequency of 17.6 % in lung cancer patients, and in 8.4 % of patients with germ cell tumors. The incidence of arterial thromboembolic events was 9.3 % and 1.7 %, respectively. The pathogenesis of cisplatin induced thromboembolism is thought to be caused by endothelial damage leading to endothelial cell dysfunction, increased von Willebrand factor plasma levels, and hypomagnesaemia.
Subject(s)
Antineoplastic Combined Chemotherapy Protocols/adverse effects , Aortic Diseases/chemically induced , Arterial Occlusive Diseases/chemically induced , Carcinoma/drug therapy , Embolism/chemically induced , Femoral Artery , Ischemia/chemically induced , Nasopharyngeal Neoplasms/drug therapy , Adolescent , Antiemetics/adverse effects , Aortic Diseases/diagnostic imaging , Aortic Diseases/therapy , Arterial Occlusive Diseases/diagnostic imaging , Arterial Occlusive Diseases/therapy , Cisplatin/administration & dosage , Contraceptive Agents, Female/adverse effects , Embolectomy , Embolism/diagnostic imaging , Embolism/therapy , Female , Femoral Artery/diagnostic imaging , Fluorouracil/administration & dosage , Humans , Ischemia/diagnostic imaging , Ischemia/therapy , Risk Factors , Smoking/adverse effects , Tomography, X-Ray Computed , Treatment OutcomeABSTRACT
Abdominal aortic calcification (AAC) measured on spine X-rays is an established risk factor for cardiovascular disease. We investigated whether AAC assessed using vertebral morphometry and a recently developed scoring system (AAC-8) is reliable and associated with cardiovascular risk factors or events. A total of 1471 healthy postmenopausal women and 323 healthy middle-aged and older men participated in 5 and 2 year trials of calcium supplements, respectively. AAC-8 was assessed on vertebral morphometry images at baseline and follow-up. In addition, 163 men also had coronary artery calcification measured using computed tomography. Cardiovascular events during the trials were independently adjudicated. We found strong inter- and intrameasurer agreement for AAC-8 (kappa > 0.87). The prevalence of AAC increased with age (p < .01) in women and in men. AAC was associated with many established cardiovascular risk factors, with serum calcium in women (p = .002) and with higher coronary calcium scores in men (p = .03). Estimated 5 year cardiovascular risk increased with increasing AAC-8 score (p < .001) in women and in men. The presence of AAC independently predicted myocardial infarction (MI) in women [hazards ratio (HR) = 2.30, p = .007] and men (HR = 5.32, p = .04), even after adjustment for estimated cardiovascular risk in women. In women, AAC independently predicted cardiovascular events (MI, stroke, or sudden death) (HR = 1.74, p = .007), and changes in AAC-8 score over time were associated with MI and cardiovascular events, even after adjustment for estimated cardiovascular risk. In summary, scoring AAC on vertebral morphometric scans is a reproducible method of assessing cardiovascular risk that independently predicts incident MI and cardiovascular events, even after taking into account traditional cardiovascular risk factors.
Subject(s)
Aorta, Abdominal/pathology , Aortic Diseases/complications , Calcinosis/complications , Calcinosis/pathology , Myocardial Infarction/complications , Spine/diagnostic imaging , Absorptiometry, Photon , Aged , Aorta, Abdominal/diagnostic imaging , Aortic Diseases/diagnostic imaging , Calcium/administration & dosage , Case-Control Studies , Dietary Supplements , Female , Follow-Up Studies , Humans , Longitudinal Studies , Male , Middle Aged , Myocardial Infarction/diagnostic imaging , Prognosis , Risk Factors , Spine/pathologyABSTRACT
BACKGROUND: Cardiovascular complications are common in beta-thalassemia major (beta-TM), mainly attributed to increased cardiac iron depositions. Early cardiovascular involvement in patients without cardiac symptoms and without cardiac iron overload has not been adequately investigated. METHODS: Twenty six patients (11 males) with beta-TM, on chelation therapy, age 23+/-4 years without cardiac iron overload (measured by magnetic resonance imaging), and 30 age and gender matched healthy controls were included in the study. Carotid-femoral and carotid-radial pulse wave velocity (PWVc-f and PWVc-r) and augmentation index (AI) were measured by SphygmoCor device; carotid intima-media thickness; left ventricular (LV) dimensions and function; left atrial (LA) volume and function were assessed by echocardiography. RESULTS: Patients with beta-TM had higher PWVc-f (8.4+/-1.4 vs 7.2+/-1.1 m/s, p=0.002) and augmentation index (21.7+/-10.9 vs 14.7+/-9.7%, p=0.04) indicating decreased aortic elastic properties; greater LV mass index (72.0+/-13.3 vs 63.8+/-11.5 g/m(2), p=0.04) and greater LA volumes. Multivariate logistic regression analysis revealed that higher PWVc-f was independently associated with higher LV mass [OR 1.74 95%CI (1.09-2.88), p=0.026]; and greater LA dimensions [OR 1.68 95%CI (1.04-2.72), p=0.035]. CONCLUSIONS: In the absence of cardiac iron overload, asymptomatic patients with beta-TM demonstrated aortic stiffening associated with increased LV mass and LA enlargement. These alterations may represent signs of early cardiovascular involvement.
Subject(s)
Aortic Diseases , Hypertrophy, Left Ventricular , beta-Thalassemia/complications , Adult , Aorta/diagnostic imaging , Aorta/pathology , Aortic Diseases/diagnostic imaging , Aortic Diseases/etiology , Aortic Diseases/pathology , Blood Flow Velocity , Brachial Artery/diagnostic imaging , Brachial Artery/pathology , Carotid Arteries/diagnostic imaging , Carotid Arteries/pathology , Echocardiography , Elasticity , Female , Humans , Hypertrophy, Left Ventricular/diagnostic imaging , Hypertrophy, Left Ventricular/etiology , Hypertrophy, Left Ventricular/pathology , Iron Overload , Linear Models , Logistic Models , Magnetic Resonance Imaging , Male , Multivariate Analysis , Pulsatile Flow , Radial Artery/diagnostic imaging , Radial Artery/pathology , Young AdultABSTRACT
BACKGROUND/AIM: Vascular calcification is thought to be associated with a high cardiovascular mortality rate in patients with end-stage renal disease. Control of hyperphosphataemia is important for the treatment of the vascular calcification. The aim of the present study was to evaluate the effects of sevelamer hydrochloride on the progression of aortic calcification in haemodialysis (HD) patients. METHODS: 42 HD patients were studied in this study and divided into two groups (sevelamer vs. calcium). Sevelamer was added and titrated up to achieve serum P control for 6 months. The estimations of aortic calcification index (ACI) by abdominal computed tomography scans were performed twice in each patient. We compared the changes in serum calcium, phosphorus, intact parathyroid hormone, and lipids in two groups. RESULTS: Serum phosphorus levels decreased significantly from 6.7 +/- 0.7 to 6.2 +/- 0.5 mg/dl with no changes in serum intact parathyroid hormone levels in the sevelamer group (p < 0.01), and increased from 6.5 +/- 1.0 to 6.7 +/- 1.1 mg/dl in the calcium group (p < 0.05). Serum calcium levels did not change in the sevelamer group and calcium group. The serum levels of total cholesterol decreased significantly from 158.5 +/- 20.7 to 146.2 +/- 24.1 mg/dl (p = 0.024) and the low-density lipoprotein cholesterol level from 65.3 +/- 14.4 to 54.7 +/- 11.6 mg/dl (p = 0.014) in the sevelamer group. Serum C-reactive protein decreased significantly from 0.14 +/- 0.13 to 0.08 +/- 0.11 mg/dl in the sevelamer group (p = 0.038) and significantly increased (0.18 +/- 0.09 vs. 0.22 +/- 0.12 mg/dl) in the calcium group (p = 0.042). The mean changes in ACI (DeltaACI) were 3.6 +/- 1.5% in the sevelamer group and 8.2 +/- 3.1% in the calcium group. CONCLUSIONS: Sevelamer allows a better serum phosphorus control compared with calcium-based phosphate binder and suppresses the progression of aortic calcification in HD patients.
Subject(s)
Aortic Diseases/drug therapy , Calcinosis/drug therapy , Chelating Agents/therapeutic use , Kidney Failure, Chronic/complications , Polyamines/therapeutic use , Renal Dialysis , Aged , Analysis of Variance , Aorta, Abdominal/diagnostic imaging , Aortic Diseases/diagnostic imaging , Aortic Diseases/etiology , Biomarkers/blood , C-Reactive Protein/analysis , Calcinosis/diagnostic imaging , Calcinosis/etiology , Calcium/blood , Calcium Carbonate/therapeutic use , Disease Progression , Female , Humans , Kidney Failure, Chronic/blood , Kidney Failure, Chronic/therapy , Lipids/blood , Male , Middle Aged , Parathyroid Hormone/blood , Phosphorus/blood , Sevelamer , Severity of Illness Index , Statistics, Nonparametric , Tomography, X-Ray ComputedABSTRACT
BACKGROUND: Coronary heart disease and ischemic stroke are among the leading causes of morbidity and mortality in adults, and cerebrovascular disease is associated with the presence of symptomatic and asymptomatic CHD. Several studies noted an association between coronary calcification and thoracic aorta calcification by several imaging techniques, but this association has not yet been examined in stable angina pectoris patients with the use of spiral computed tomography. OBJECTIVES: To examine by spiral CT the association between the presence and severity of CC and thoracic aorta calcification in patients with stable angina pectoris. METHODS: The patients were enrolled in ACTION (A Coronary Disease Trial Investigating Outcome with Nifedipine GITS) in Israel. The 432 patients (371 men and 61 women aged 40-89 years) underwent chest CT and were evaluated for CC and aortic calcification. RESULTS: CC was documented in 90% of the patients (n = 392) and aortic calcification in 70% (n = 303). A significant association (P < 0.05) was found between severity of CC and severity of aortic calcification (as measured by area, volume and slices of calcification). We also found an association between the number of coronary vessels calcified and the presence of aortic calcification: 90% of patients with triple-vessel disease (n = 157) were also positive for aortic calcification (P < 0.05). Age also had an effect: 87% of patients > 65 years (n=219) were positive for both coronary and aortic calcification (P = 0.005) while only 57% < or = 65 (n = 209) were positive for both (P = 0.081). CONCLUSIONS: Our study demonstrates a strong association between the presence and severity of CC and the presence and severity of calcification of thoracic aorta in patients with stable angina pectoris as detected by spiral CT.
Subject(s)
Angina Pectoris/diagnostic imaging , Aorta, Thoracic/diagnostic imaging , Aortic Diseases/diagnostic imaging , Calcinosis/diagnostic imaging , Nifedipine/therapeutic use , Tomography, Spiral Computed/methods , Adult , Aged , Aged, 80 and over , Angina Pectoris/drug therapy , Angina Pectoris/etiology , Aortic Diseases/complications , Calcinosis/complications , Calcinosis/drug therapy , Coronary Vessels/pathology , Double-Blind Method , Female , Follow-Up Studies , Humans , Male , Middle Aged , Prognosis , Risk Factors , Severity of Illness Index , Vasodilator Agents/therapeutic useSubject(s)
Angina Pectoris , Aorta, Thoracic , Aortic Diseases/diagnostic imaging , Calcinosis/diagnostic imaging , Coronary Vessels , Nifedipine/therapeutic use , Tomography, Spiral Computed/methods , Adult , Aged , Aged, 80 and over , Angina Pectoris/diagnostic imaging , Angina Pectoris/drug therapy , Angina Pectoris/etiology , Aortic Diseases/complications , Calcinosis/complications , Female , Humans , Male , Middle Aged , Prognosis , Risk Factors , Vasodilator Agents/therapeutic useABSTRACT
OBJECTIVE: The prognostic factors and treatment options for thoracic aortic intramural hematoma are controversial. The purpose of this study was to determine the most suitable treatment of this condition in very elderly patients. METHODS: In a review of the world literature, eight octogenarians with thoracic aortic intramural hematoma were found; to these the three cases reported here must be added. The descending thoracic aorta was involved in eight cases and the ascending/arch in three. RESULTS: In spite of patients' poor general conditions, the medical treatment group showed survival rates of 85.7% (descending) and 66.6% (ascending/arch), respectively. CONCLUSION: Extensive atherosclerotic changes of the aortic wall in the elderly, combined with control of hypertension, may probably prevent thoracic aortic intramural hematoma from progressing to dissection, with a favourable outcome. An earlier and more accurate preoperative diagnosis by modern diagnostic techniques, including spiral computed tomography (CT), as were performed in our own patients, will allow optimal treatment and increased patient survival.
Subject(s)
Aortic Diseases/drug therapy , Hematoma/drug therapy , Nifedipine/therapeutic use , Vasodilator Agents/therapeutic use , Aged , Aged, 80 and over , Analgesics/therapeutic use , Aorta, Thoracic , Aortic Diseases/diagnostic imaging , Aortic Diseases/etiology , Aortography , Arteriosclerosis/complications , Drug Therapy, Combination , Female , Hematoma/diagnostic imaging , Hematoma/etiology , Humans , Hypertension/complications , Hypertension/drug therapy , Male , Nitroprusside/therapeutic use , Tomography, X-Ray ComputedABSTRACT
OBJECTIVE: To identify an analog waveform characteristic of smokers by Doppler sonography, which reflects their atherogenic state, and to determine if the presence of this aberrant waveform will increase the sensitivity of the ankle pressure index (API) peripheral Doppler examination. Also, to examine the relationship between pac-yr smoked and arterial compliance. DESIGN: A cross-sectional design was used to examine the diastolic component of the triphasic arterial analog waveform. A comparison between the Doppler studies of smokers and nonsmokers was constructed. SETTING: A university-based study from the Department of Applied Physiology, Teachers College, Columbia University. PARTICIPANTS: Studied were a total of 140 sedentary subjects consisting of 70 controls and 70 smokers. Control subjects were sedentary and never smoked. Each group consisted of an equal number of male and female subjects. Smoking subjects had smoked 37.8 +/- 21.4 mean pac-yr and were sedentary. No subject had hypertension, diabetes, hyperlipidemia or cardiac disease. They had no evidence of myocardial infarction, arrhythmia, aortic coarctation, cardiac valve disease or peripheral arterial disease. Anthropometric measurements and percent body fat were recorded. A predictive, oxygen-consumption, bike ergometer test was performed to determine aerobic capacity. The standard API Doppler examination and arterial diastolic flow analysis were performed with A-mode Doppler ultrasound on all subjects. MAIN OUTCOME MEASURE: The amplitude of the diastolic component of the triphasic arterial analog waveform was examined by diastolic flow analysis. This method has been shown to quantify arterial compliance, which is a correlate of arteriosclerotic disease. RESULTS: A statistically significant difference (p < .001) existed between the mean arterial compliance values of the control and smoking groups. The mean arterial compliance value for the control group was 21.3 +/- 3.7% and 4.9 +/- 4.7% for the smoking group. The mean quantity of arterial compliance in the control group was 4.3 times greater than that observed in the smoking group. A significant inverse-linear relationship was observed between pac-yr smoked and arterial compliance (p < .001). CONCLUSION: When utilizing Doppler to identify lower-extremity occlusive disease, these results demonstrate that smokers display a distinctive analog waveform. The morphology of the waveform is characterized by an attenuated diastolic component of the analog triphasic complex. This finding reflects an advanced state of arterial disease. In our study, this characteristic waveform was identified when API remained negative. When examining the results of a Doppler peripheral arterial study in a claudication patient, the identification of this waveform suggests that advanced atherogenic changes have occurred.